The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1941, 40: 73-80.
Copyright © 1941 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ecker, E. E.
Right arrow Articles by Pillemer, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ecker, E. E.
Right arrow Articles by Pillemer, L.

Anti-Coagulants and Complementary Activity1

An Experimental Study

E. E. Ecker and L. Pillemer

From the Institute of Pathology and the University Hospitals of Western Reserve University, Cleveland, Ohio

Abstract

1. Heparin, capable of reacting with prothrombin or thrombin (20), inactivates complement only in quantities out of all proportion to its anti-coagulative ability.
2. The synthetic anti-coagulants, the sodium salts of polyvinyl sulfuric and cellulose sulfuric acids, are from 75 to 100 times as anti-complementary as heparin, while possessing only 1/15 of the anti-coagulative ability of the purified heparins.
3. Anti-coagulants capable of reacting with calcium, failed to inactivate complement under the conditions employed.
4. Protamine, which probably inhibits coagulation by reacting with the thromboplastic factor (20), likewise required amounts for complement inactivation out of proportion to its anti-coagulative ability.
5. The anti-complementary action of the anti-coagulants may be attributed to their acidic or basic nature, and to their high molecular size.
6. No definite correlation exists between the inactivation of complement and the inhibition of coagulation.

Footnotes

1 Aided by a grant from the commonwealth Fund.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
N. DI SIMONE, M. P. LUIGI, D. MARCO, D. N. FIORELLA, D. SILVIA, D. M. CLARA, and C. ALESSANDRO
Pregnancies Complicated with Antiphospholipid Syndrome: The Pathogenic Mechanism of Antiphospholipid Antibodies: A Review of the Literature
Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 505 - 514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1941 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1941 by The American Association of Immunologists, Inc. All rights reserved.